SHL Telemedicine Ltd. (NASDAQ:SHLT) Short Interest Update

SHL Telemedicine Ltd. (NASDAQ:SHLT) was the recipient of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,300 shares, a drop of 50.0% from the March 31st total of 2,600 shares. Based on an average trading volume of 3,800 shares, the days-to-cover ratio is presently 0.3 days.

Wall Street Analysts Forecast Growth

Separately, Litchfield Hills Research reaffirmed a “buy” rating and set a $11.00 target price on shares of SHL Telemedicine in a research note on Thursday, March 14th.

SHL Telemedicine Price Performance

SHLT traded up $0.34 on Friday, hitting $5.55. The company had a trading volume of 471 shares, compared to its average volume of 3,766. SHL Telemedicine has a 1 year low of $4.86 and a 1 year high of $12.75. The company’s fifty day moving average price is $5.98 and its 200 day moving average price is $7.61. The company has a quick ratio of 2.10, a current ratio of 2.30 and a debt-to-equity ratio of 0.20.

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center.